Comment on Pradhan et al. Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes. Diabetes Care 2025;48:444

Edy Kornelius2026-02-052026-02-052025-07-2110.2337/dc25-0451https://scholars.csmu.edu.tw/handle/123456789/5288[SDGs]SDG3Comment on Pradhan et al. Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes. Diabetes Care 2025;48:444–454journal-article